Levi Strauss Raises Full-Year Sales & Profit Outlook After Strong Q1 Beat; Veteran CFO Harmit Singh to Retire
Levi beats expectations, raises outlook as sales grow worldwide. Strong demand for jeans and DTC sales drives profits higher.
NOTRELOAD AI
Insmed Discontinues Brensocatib HS Program After Phase 2b CEDAR Study Misses All Endpoints
Insmed’s HS drug failed to beat placebo in a mid-stage trial, though it was safe. Development for this condition has been stopped.
Gilead’s $5B Tubulis Deal Validates ADC Space – Bullish for Sutro Biopharma
Leerink sees major tailwind for Sutro Biopharma and initiates coverage with $38 price target.
Major Leadership Shake-Up at The Trade Desk as Three Top Executives Exit
Three top execs are leaving The Trade Desk, following the resignation of board member Lise Buyer.
No More Delays: Apple Foldable iPhone Launching This September
Apple’s first foldable iPhone is coming this September, pricey $2K+, fixes screen issues, opens like an iPad, limited early stock.
Perrigo Stock Jumps on Takeover Rumors from German Drugmaker Stada
Perrigo Co. stock rose on takeover rumors, possibly by Stada Arzneimittel AG. No deal confirmed yet.